Oncology News, Insights, Stories by OncoDaily

16th World ADC London
2026-02-23 - 2026-02-26 | ExCeL London, One Western Gateway, Royal Victoria Dock, London, E16 1XL, United Kingdom
﻿The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance.
The summit will host over 800 senior European ADC decision-makers, including biopharma executives, clinicians, investors, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs, specifically highlighting novel cytotoxic and non-cytotoxic payloads, dual/bispecific ADCs, non-antibody conjugates, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact.
The 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking, offering comprehensive One-on-One Partnering and informal networking opportunities, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content.
View the 2026 agenda here.
Registration link.
Full Event Guide link.
You can find more posts on ADCs on OncoDaily.

Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
2026-02-24 - 2026-02-25 | Queensland
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026.
The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment.
The program will feature invited talks from leading scientists on innovative therapeutic strategies, including novel NK, T, and myeloid cell therapies, mRNA therapies, cytokine targeting, and new combinatorial immune checkpoint blockade strategies.

9th CAR-TCR Summit Europe 2026
2026-02-24 - 2026-02-26 | Park Plaza Victoria London, 239 Vauxhall Bridge Road, London, Greater London (England), SW1V 1EQ, United Kingdom
The 9th CAR-TCR Summit Europe 2026 is the essential, industry-dedicated forum for next-generation cell therapy, scheduled from February 24–26, 2026, in London, UK, at the Park Plaza Victoria hotel. Organized by Hanson Wade, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies, including novel CAR, TCR, NK, and Macrophage designs, engineering to improve durability, and solutions to overcome bottlenecks in manufacturing, regulatory approval, and commercialization.
Full Event Guide Link.

Colorectal Liver Metastasis Consensus Conference
2026-02-24 - 2026-02-26 | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday, February 24, to Thursday, February 26, 2026, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston, Texas.
Hosted by The University of Texas MD Anderson Cancer Center, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases, culminating in a consensus statement brought forth by leading experts, clinicians, and researchers in the field.
Register.

ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
2026-02-25
The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases.
The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice, such as optimal biomarker testing, the integration of immunotherapy, and the management of treatment-related toxicities.
Register.

2026 ASCO GU Cancers Symposium
2026-02-26 - 2026-02-28 | Moscone West, 800 Howard Street, San Francisco, United States
The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28, 2026, at Moscone West in San Francisco, California.
This premier event, hosted by the American Society of Clinical Oncology (ASCO), will focus on the latest advancements in the prevention, diagnosis, and treatment of genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. The symposium will feature groundbreaking research presentations, expert-led educational sessions, and in-depth discussions on key topics in GU oncology.
Attendees can expect a rich program that combines plenary lectures, oral abstract presentations, poster sessions, and interactive workshops. The event emphasizes multidisciplinary collaboration, bringing together medical oncologists, urologists, radiation oncologists, pathologists, advanced practice providers, nurses, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology, immunotherapy, novel targeted therapies, survivorship, and health equity in GU cancers, highlighting both scientific innovation and patient-centered care.
The symposium also offers networking opportunities with leading global experts, enabling participants to exchange knowledge, discuss challenges, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available, allowing wider access for international participants.
Registration.
You can find more posts featuring ASCO on OncoDaily.

2026 Translating Evidence to Action: Elevating Cancer Care
2026-02-26 09:00 - 17:00 (America/Halifax)
The “2026 Translating Evidence to Action: Elevating Cancer Care“ is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK), scheduled as a live virtual conference on Thursday, February 26, 2026.
This program is designed for healthcare professionals across all disciplines to explore how evidence-based research can be translated into meaningful quality improvements in clinical practice and patient outcomes. The conference features exemplary quality improvement projects, practice-based initiatives, two dynamic Rapid-Fire Poster Sessions, and a keynote address on “Technology with a Human Pulse: Advancing Patient Care with Innovation and Intention.” Participants can earn up to 6.50 AMA PRA Category 1 Credits.
Register.

Updates on Advanced Breast Cancer: Local Management and Other New Perspectives
2026-02-27 - 2026-02-28 | Houston Marriott Medical Center/Museum District, 6580 Fannin Street, Driveway Entrance on, 1730 Dryden Rd, Houston, TX, 77030, United States
The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day, in-person event scheduled for February 27–28, 2026, at the Houston Marriott Medical Center in Houston, TX.
Hosted by The University of Texas MD Anderson Cancer Center, the activity’s main goal is to emphasize the integration of novel therapies and diagnostic tools into clinical practice, focusing on areas like liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC).
Register.

Call-on Congress by Fight Colorectal Cancer
2026-03-01 17:00 - 2026-03-03 21:00 (America/Halifax) | Hilton Arlington National Landing, 2399 Richmond Highway Arlington, VA 22202 United States, Arlington, VA, 22202, United States
Now in its 20th year, Call-on Congress is Fight Colorectal Cancer’s (Fight CRC) signature advocacy event – founded on Nancy Roach’s belief that patients must have a seat at the policy table. Each year, patients, survivors, caregivers, and healthcare professionals gather in Washington, D.C. to meet with lawmakers, share their stories, and drive policy change.
Registration Includes:

Fight CRC swag bag
Virtual and in-person advocacy training
Exclusive advocacy resources
Scheduled congressional meetings
Meals (Mon: breakfast and lunch | Tue: breakfast and dinner)

Preparation Tips:

Review training materials and key talking points in advance
Join the Community of Champions for updates, hotel info, and volunteer opportunities
Wear blue! Casual for training, business casual for Capitol Hill, and comfortable shoes

Hotel and Scholarships:
Discounted hotel rooms are available for $185/night.
Scholarships are offered to make attendance accessible:

Advocate Travel Scholarship for adults
Junior Advocate Leadership Scholarship for youth (ages 13–18) and a parent/guardian.

You can find more posts featuring Fight Colorectal Cancer.

ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich
2026-03-04 - 2026-03-05 | Zurich, Switzerland
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer.
The event is scheduled to take place on March 4–5, 2026, in Zurich, Switzerland.
The application deadline for participation is January 7, 2026, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing, using results for optimal patient selection, and discussing the proactive management of precision-medicine-based treatments.
Apply.

Provider Education Series - Lung Health Foundation
2026-03-05 13:00 - 14:00 (America/Halifax) | Queensland
The Lung Health Foundation is offering a free, accredited virtual “Lunch and Learn” series – the Provider Education Series – consisting of three one-hour sessions designed to deliver high-impact, evidence-based education to healthcare professionals.
These sessions will provide practical insights from expert speakers on the diagnosis, treatment, and management of lung diseases, with a focus on severe asthma, COPD, and lung cancer. Participants will enhance their clinical knowledge, receive updates on current lung cancer risk assessment and screening guidelines, and earn valuable CPD credits to support best practices.

Session 1: September 18, 2025: What You Need to Know – Managing Severe Asthma in Your Practice
Session 2: November 27th, 2025: What You Need to Know – Optimizing COPD Treatment and Reducing Exacerbations in Your Practice
Session 3: March 5th, 2026: What You Need to Know – Managing Lung Cancer Risk Assessment in Your Practice

APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit
2026-03-06 - 2026-03-07 | The Ballantyne Hotel, Charlotte, Ballantyne Commons Parkway Charlotte, Charlotte, 28277, United States
The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7, 2026, bringing oncology clinicians together for a focused, two-day CE program dedicated to the latest advances in cancer care.
Designed with and for advanced practice providers, this summit delivers evidence-based updates, practical management strategies, and collaborative learning to strengthen patient care and team communication across the oncology continuum.
Register.

Pathology Update 2026
2026-03-06 - 2026-03-08 | International Convention Centre Sydney, Australia, 14 Darling Dr, Sydney NSW 2000, Australia, Sydney, NSW, 2000, Australia
Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8, 2026, in Sydney, NSW.
The meeting provides a multi-disciplinary pathology program for pathologists, scientists, and trainees, focusing on new developments and challenges in the field under the theme, “Many Paths. Shared Focus. Stronger Together.” The event will include plenary sessions, workshops, and abstract presentations from both local and international pathology experts, coinciding with the celebration of the RCPA’s 70th anniversary.

26th Multidisciplinary Management of Cancers: A Case-Based Approach
2026-03-06 08:00 - 2026-03-08 12:15 (America/Halifax) | The Meritage Resort and Spa, 875 Bordeaux Way, Napa, CA, 94558, United States
The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology.
The meeting features tumor board–style case discussions across breast, gastrointestinal, genitourinary, hematologic, lymphoma, and thoracic cancers, led by faculty and expert panels from Stanford, UC Davis, UC San Francisco, and the broader oncology community.
Register here.

OPN Pacific Northwest Chapter Conference 2026
2026-03-07 | Crowne Plaza Portland-Downtown Conv Ctr, 1441 NE 2nd Ave, Portland, OR, 97232, United States
The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network, scheduled for March 7, 2026.
The conference will be held at the Crowne Plaza in Portland, Oregon, United States. Designed for hematology/oncology pharmacy clinicians, including pharmacists and technicians, the event provides a platform to network, collaborate, and share the latest evidence-based strategies and best practices to advance patient care within the oncology pharmacy field.
Register.

ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
2026-03-11 - 2026-03-13 | Manchester, United Kingdom
The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom.
The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points.
The learning objectives cover the full spectrum of thoracic oncology, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC), with a focus on advanced treatments like targeted agents for actionable driver mutations, novel immunotherapies, and palliative care.
Apply.

12th ImmunoTherapy of Cancer Conference (ITOC12)
2026-03-12 - 2026-03-14 | Medical Center Großhadern of Ludwig-Maximilian-University, Marchioninistrasse 15, Munich, 81377, Germany
The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups, including the ITOC Association, the Tumor Centre in Munich (TZM), and the German Cancer Consortium (DKTK), the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.

The ESMO Sarcoma and Rare Cancers Congress 2026
2026-03-12 08:00 - 2026-03-14 17:00 (Europe/Zurich) | “Palazzo dei Congressi” in Lugano, Switzerland, Piazza Indipendenza 4, Lugano, 6900, Switzerland
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours.
The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations, educational lectures, multidisciplinary tumour boards, guidelines updates, and dedicated discussions for young oncologists. With opportunities for clinicians, researchers, industry professionals, and patient advocates to connect and collaborate, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.

APPOS Boston 2026: Advanced Practice Providers Oncology Summit
2026-03-13 - 2026-03-14 | The Westin Waltham Boston, 70 Third Ave., Waltham, MA, 02451, United States
The APPOS Boston 2026: Advanced Practice Providers Oncology Summit returns to Massachusetts, a two-day continuing education conference taking place March 13–14, 2026, in Waltham.
Designed for advanced practice providers, this program delivers the latest updates in multidisciplinary cancer care, practical patient management, and interprofessional collaboration. Attendees will have the opportunity to earn CE credits while gaining evidence-based strategies to enhance oncology practice and improve communication across the healthcare team.
Register.

Inaugural Oncology Nursing Symposium 2026
2026-03-13 - 2026-03-14 | Embassy Suites by Hilton Charlotte Concord Golf Resort & Spa, 5400 John Q. Hammons Dr NW, Concord, NC, 28027, United States
The Inaugural Oncology Nursing Symposium 2026, hosted by the South Piedmont AHEC in conjunction with Advocate Health, is a crucial two-day, in-person event for nurses, scheduled for March 13–14, 2026.
The symposium will be held at the Embassy Suites by Hilton Charlotte Concord in Concord, North Carolina. This educational gathering is aimed at a wide audience of oncology nurses, including frontline clinicians, nurse leaders, educators, and researchers, and is accredited for a maximum of 7.50 ANCC contact hours.
Agenda and Details.
Register.

2026 CRUSH Colorectal Cancer 5K
2026-03-14 | The River Church, 4425 Ben Franklin Blvd., Durham, NC, 27704, United States
The CRUSH Colorectal Cancer 5K Walk/Run, which supports research at the Duke Cancer Institute, will take place on Saturday, March 14, 2026, at 10:00 a.m.
The event will be held at The River Church. This event aims to raise awareness for colorectal cancer, provide access to colorectal cancer screenings, and feature community exhibitors.

2026 OPN California - Hawaii Chapter Conference
2026-03-14 | Sheraton Park Hotel at the Anaheim Resort, 1855 S Harbor Blvd, Anaheim, CA, 92802, United States
The 2026 OPN California – Hawaii Chapter Conference is a one-day regional summit organized by the Oncology Pharmacy Network (OPN) and Horizon CME, scheduled for March 14, 2026, at the Sheraton Park Hotel at the Anaheim Resort in Anaheim, California, United States.
This event is specifically designed for hematology/oncology pharmacy clinicians (pharmacists, pharmacy technicians, and other healthcare professionals) and focuses on optimizing cancer care by providing the latest evidence-based strategies and fostering networking and collaboration within the community.
Register.

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations
2026-03-15 - 2026-03-18 | Fairmont Le Château Frontenac, 1 Rue des Carrières, Québec, Québec, G1R 5J5, Canada
The Keystone Symposia conference, “Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations,” will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada.
This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, with the goal of guiding strategies to overcome these hurdles and improve clinical outcomes; the sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition, and advanced technologies like spatial imaging and AI.

ESMO Targeted Anticancer Therapies Congress 2026
2026-03-16 - 2026-03-18 | Palais des Congrès de Paris, 2 Pl de la Pte Maillot, Paris, Île-de-France, 75017, France
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development.
The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The event serves as a dynamic, multi-stakeholder meeting, uniting researchers, industry leaders, investors, and regulators to share new data, foster collaboration, and tackle the challenges of advancing early clinical development in oncology.
Elena Garralda, Carlos Gomez-Roca, and Cristian Massacesi serve as the co-chairs.

The Tumour Ecosystem: From Mechanisms to Novel Therapeutics
2026-03-17 - 2026-03-19 | Centro Congressi Giovanni XXIII, Viale Papa Giovanni XXIII, 106, Bergamo, Lombardy, 24121, Italy
The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo, Italy. Organized by the European Association for Cancer Research (EACR), the event’s venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment, covering how cancer cells interact with the immune system, stroma, and nervous system, with the goal of developing new and efficient therapeutic strategies.
You can find more posts featuring EACR on OncoDaily.

From Protocol to Publication: A Practical Course in Clinical Research
2026-03-17 - 2026-03-19 | Queensland
The “From Protocol to Publication: A Practical Course in Clinical Research” is an exclusive, in-person training event organized by the European School of Oncology (ESO). Scheduled for 17 to 18 March 2026 in Milan, Italy, this advanced, two-day workshop is reserved only for the ten members of the ESO College who achieve the highest scores in two prerequisite online courses.
Led by Course Leaders Luca Bertolaccini (IT) and Isabelle Schmitt-Opitz (DE/CH), the course offers highly interactive sessions, hands-on workshops, and peer-review simulations designed to bridge the gap between theoretical knowledge and real-world research practice, covering every phase from protocol design to publication strategies.
You can find more posts featuring ESO on OncoDaily.

TROG Annual Scientific Meeting 2026
2026-03-17 - 2026-03-20 | Pullman Melbourne Albert Park, 65 Queens Rd, Albert Park VIC 3004, Australia, Melbourne, Victoria, 3004, Australia
The 38th TROG Annual Scientific Meeting (ASM), hosted by the Trans-Tasman Radiation Oncology Group (TROG) Cancer Research, will be held in Melbourne from March 17 to 20, 2026.
The conference theme is “Driving Intelligent Trials,” which focuses on using smarter designs, AI-driven insights, and stronger trial systems to achieve better research outcomes in radiation oncology.
The meeting’s sub-themes include: Precision and Performance (for smarter, AI-enabled trial designs), Equity in Motion (for research involving consumers, underserved, rural, and First Nations populations), and Fuelling the Future (for sustaining a strong research workforce and embedding research into clinical care). The ASM will serve as a key platform for collaboration, learning, and professional exchange on the latest developments in clinical trials and innovation in practice.

The ICHNO 2026
2026-03-19 08:00 - 2026-03-21 17:00 (Europe/Madrid) | Fibes – Conference and Exhibition, Ave. Alcalde Luis Uruñuela, 1, Seville, 41020, Spain
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.”
This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology, grounded in biology and focused on the individual.
With global thought leaders, impactful research, and opportunities for meaningful dialogue, ICHNO 2026 will be a vital platform for education, exchange, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO), Giovanni Succo (EHNS), and Yungan Tao (ESMO).
More posts featuring European Society for Radiotherapy and Oncology on OncoDaily.

ANZGOG 2026 Annual Scientific Meeting
2026-03-25 - 2026-03-27 | Gold Coast Convention and Exhibition Centre, 2684 - 2690 Gold Coast Highway, Broadbeach, Queensland, 4218, Australia
The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM, themed “On the Edge: Translating Innovation into Action,” is scheduled for March 25–27, 2026, on the Gold Coast, Queensland.
It serves as a dynamic forum for national and international experts – including gynaecological medicine, radiation, and surgical oncologists, researchers, nurses, and industry partners – to engage in bold thinking and action-oriented discussion focused on the future of gynaecological cancer research, particularly around emerging technologies like artificial intelligence, the urgent need for pragmatic trials, and transforming insights from molecular studies and the lived experience of survivors into clinical impact.

2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules
2026-03-25 - 2026-03-27 | El Conquistador Tucson, A Hilton Resort, 10000 N Oracle Rd, Tucson, AZ, 85704, United States
The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27, 2026, in a hybrid format with options to attend in Tucson, Arizona, or virtually.
Organized by the Society for Immunotherapy of Cancer (SITC), the program will bring together experts in cell therapy, drug development, and immuno-oncology to focus on the timely topic of combining next-generation immuno-oncology agents with cellular therapies to treat cancer.
The organizing com
mittee includes Kristen Hege, MD, Gordon Moody, MS, Daniel Powell, Jr., PhD, and Evan Weber, PhD, and registration for the event opens on August 18, 2025.
Register.
Abstract Submission.
